SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905718-21-001151
Filing Date
2021-08-27
Accepted
2021-08-27 17:02:51
Documents
2
Group Members
HALE BIOPHARMA VENTURES LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D dermata_13daug172021.htm SC 13D 55209
2 JOINT FILING AGREEMENT dermata_ex1aug172021.htm EX-1 8922
  Complete submission text file 0000905718-21-001151.txt   65546
Mailing Address 1042-B NORTH EL CAMINO REAL, SUITE 430 ENCINITAS CA 92024
Business Address
HALE DAVID F (Filed by) CIK: 0001024004 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Subject) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92822 | Film No.: 211219951
SIC: 2834 Pharmaceutical Preparations